The GM1 ganglioside hastens the reduction of hyperemotionality after septal lesions.
The purpose of the present study was to assess the effects of ganglioside treatment on changes in emotional, activity, and avoidance behaviors following septal brain damage. Rats were treated with GM1-gangliosides either before and after septal lesions, or only after septal lesions and tested for emotionality on 10 consecutive days beginning on the second day after surgery. The ganglioside treatment decreased the emotionality of rats with septal damage on the first test day, and enhanced their rate of recovery to control levels of emotionality. Septal rats treated with gangliosides had activity, rearing, and avoidance behaviors equivalent to nontreated septal rats; however, lesioned rats treated with GM1 showed reduced intertrial crossings during avoidance conditioning. These results suggest that the changes in emotional behavior of septal rats treated with GM1 occur shortly after the lesion.
D000818:Animals; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D004644:Emotions / Q000187:drug effects*; D005677:G(M1) Ganglioside / Q000627:therapeutic use*; D008297:Male; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D012688:Septum Pellucidum
D005677:G(M1) Ganglioside